Detailed activity profile, predicted human pharmacokinetics of E-1010 presented at ICAAC Sep. 30, 1999
News from ICAAC: characterization of water-soluble prodrug of the azole antifungal Sch-56592 Sep. 30, 1999
DHFR inhibitors designed by Roche for activity against resistant Gram-positive bacteria Sep. 30, 1999
Novel class of quinoline-indoles: discovery, activity and pharmacokinetics discussed at ICAAC Sep. 30, 1999
New Lilly compounds LY-314177 and LY-311912 active against influenza A infections in mice Sep. 29, 1999
Clinical candidate selected by Wakunaga from series of antibacterial 8-methylquinolones Sep. 29, 1999
J-110441: a broad-spectrum carbapenem-derived beta-lactamase inhibitor designed at Banyu Sep. 29, 1999